Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 July 2005, Vol. 106, No. 2, pp. 635-640.
Prepublished online as a Blood First Edition Paper on April 5, 2005; DOI 10.1182/blood-2004-10-3919.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-10-3919v1
106/2/635    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hebeis, B.
Right arrow Articles by Turner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hebeis, B.
Right arrow Articles by Turner, M.
Related Collections
Right arrow Immunobiology
Right arrow Signal Transduction
Right arrowRelated Article in Blood Online
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Vav proteins are required for B-lymphocyte responses to LPS

Barbara Hebeis, Elena Vigorito, Dorottya Kovesdi, and Martin Turner

From the Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.

B lymphocytes respond to bacterial lipopolysaccharide (LPS) through Toll-like receptor 4 (TLR4) and CD180 (previously called RP105). We show here that the responses of B lymphocytes to LPS require the function of the Vav family of guanine nucleotide exchange factors. Vav1-mutant mice generate defective humoral immunoglobulin G (IgG) responses following administration of low doses of LPS but respond normally to higher doses, while mice lacking both Vav1 and Vav2 manifest defective responses even after a high dose of LPS. Vav1/2-mutant B cells fail to divide extensively in vitro in response to LPS or CD180, while deficiency of Vav1 alone impairs CD180-but not LPS-driven proliferation. Likewise, activation of Akt (a PI3K [phosphatidylinositol 3-kinase] target) and phosphorylation of I{kappa}B{alpha} in response to CD180 or LPS required Vav1 and Vav2, while Vav1 deficiency led to defective responses to CD180. In addition, activation of ERK (extracellular signal regulated kinase) required Vav1 and Vav2 in response to CD180 but was Vav1 and vav2 independent in response to LPS. Induction of CD86 and CD25 by anti-CD180 also required Vav function, as did the induction of the antiapoptotic protein Bcl-xL (B-cell leukemia XL). These data provide evidence for the function for the Vav proteins in regulating the responses of B cells to LPS. (Blood. 2005;106:635-640)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Vav: a newcomer in innate receptor signaling
Tomohiro Kurosaki
Blood 2005 106: 389-390. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
F. D. Oakley, R. L. Smith, and J. F. Engelhardt
Lipid Rafts and Caveolin-1 Coordinate Interleukin-1{beta} (IL-1{beta})-dependent Activation of NF{kappa}B by Controlling Endocytosis of Nox2 and IL-1{beta} Receptor 1 from the Plasma Membrane
J. Biol. Chem., November 27, 2009; 284(48): 33255 - 33264.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Shibolet, C. Giallourakis, I. Rosenberg, T. Mueller, R. J. Xavier, and D. K. Podolsky
AKAP13, a RhoA GTPase-specific Guanine Exchange Factor, Is a Novel Regulator of TLR2 Signaling
J. Biol. Chem., November 30, 2007; 282(48): 35308 - 35317.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Stephenson, A. V. Miletic, T. Kloeppel, S. Kusin, and W. Swat
Vav Proteins Regulate the Plasma Cell Program and Secretory Ig Production
J. Immunol., December 15, 2006; 177(12): 8620 - 8625.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Utomo, X. Cullere, M. Glogauer, W. Swat, and T. N. Mayadas
Vav Proteins in Neutrophils Are Required for Fc{gamma}R-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox)
J. Immunol., November 1, 2006; 177(9): 6388 - 6397.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020